Methods and materials for generating CD8
View Patent ↗This document provides methods and materials for generating CD8 − T cells having the ability to recognize cancer cells expressing a HER2/neu polypeptide. For example, methods and materials for using a polypeptide consisting of an SLAFLPESFD amino acid sequence in vivo or in vitro to generate CD8 + T cells having the ability to recognize and lyse cancer cells expressing a HER2/neu polypeptide are provided.
1. A composition comprising an immunogenically effective amount of a polypeptide and an adjuvant selected from the group consisting of a CpG oligonucleotide, monophosphoryl lipid A, and Montanide ISA-51, wherein the sequence of said polypeptide consists of the amino acid sequence set forth in SEQ ID NO:1.
2. The composition of claim 1 , wherein said adjuvant is said CpG oligonucleotide.
3. The composition of claim 1 , wherein said adjuvant is said monophosphoryl lipid A.
4. The composition of claim 1 , wherein said adjuvant is said Montanide ISA-51.